Is Revvity, Inc. overvalued or undervalued?

As of 31 October 2025, the valuation grade for Revvity, Inc. has moved from attractive to very expensive, indicating a significant shift in its market perception. The company appears to be overvalued based on its current metrics, including a P/E ratio of 33, a Price to Book Value of 1.42, and an EV to EBITDA ratio of 15.29. In comparison, peers such as Hologic, Inc. have a fair valuation with a P/E ratio of 21.83, while The Cooper Companies, Inc. is also considered very expensive with a P/E of 34.28.
The stock has underperformed against the S&P 500 across multiple periods, with a year-to-date return of -16.70% compared to the S&P 500's 16.30%, and a three-year return of -27.07% versus 76.66% for the index. This underperformance further supports the conclusion that Revvity, Inc. is currently overvalued in the market.